Risk locus for psoritic arthritis
The present invention provides methods for diagnosing psoriatic arthritis (PsA) in an individual. Specifically, the method relates to detecting the presence or absence of an intergenic deletion between the human ADAMTS9 and MAGI1 genes. Also provided herein are methods for determining whether a subject has a risk of developing PsA. The methods described herein can be used for selecting a treatment of a subject suspected of having PsA.
- Health technology: